Company: NMP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001213900-25-075714
Chunk: 181

Company: NMP Acquisition Corp.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part II, Item 8
Chunk 181
---
 30, 2025. Based upon
their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined
in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective.

We do not expect that our
disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter
how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls
and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints,
and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures,
no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies
and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the
likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential
future conditions.

Changes in Internal Control over Financial
Reporting

There were no changes in
our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the
most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial
reporting.

6

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

In addition to the other information set forth in this report, you should
carefully consider the factors discussed in “Risk Factors” of our Prospectus, dated June 30, 2025, which could materially
affect our business, financial condition or future results. There have been no material changes during the 2025 fiscal year to the risk
factors that were included in the Prospectus.

Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.

Unregistered Sales of Equity Securities

There are no transactions
that have not been previously included in a Current Report on Form 8-K.

Use of Proceeds

On
July 2, 2025, we consummated the IPO of 10,000,000 Units, at a purchase price of $10.00 per Public Share, generating proceeds of $100,000